Stock Market News

Morgan Stanley sees FDA approval of GILD's Lenacapavir

Feb 25, 2025 - 16:51
 0
Read More

Tags:

Previous Article

Navigating Rough Market Conditions Ahead

Next Article

Home Depot rises as fourth-quarter sales help offset disappointing guidance

Related Posts

iRhythm stock rises on strong Q4 results and outlook

iRhythm stock rises on strong Q4 results and outlook

Feb 21, 2025  0

Mexico stocks higher at close of trade; S&P/BMV IPC up 0.27%

Mexico stocks higher at close of trade; S&P/BMV IPC up ...

Feb 10, 2025  0

New York City sues Trump for taking back $80 million FEMA grant for migrants

New York City sues Trump for taking back $80 million FE...

Feb 22, 2025  0